Thrivent Financial for Lutherans’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-117,561
Closed -$38.3M 2609
2024
Q1
$38.3M Sell
117,561
-2,837
-2% -$697K 0.08% 299
2023
Q4
$22.9M Buy
120,398
+34,025
+39% +$6.43M 0.05% 404
2023
Q3
$17.2M Buy
86,373
+22,635
+36% +$5.35M 0.04% 451
2023
Q2
$18.2M Buy
63,738
+17,939
+39% +$4.98M 0.04% 448
2023
Q1
$9.93M Buy
45,799
+2,416
+6% +$471K 0.02% 609
2022
Q4
$8.92M Buy
43,383
+4,228
+11% +$1.07M 0.02% 624
2022
Q3
$10.9M Buy
39,155
+29,765
+317% +$7.57M 0.03% 566
2022
Q2
$1.79M Buy
+9,390
New +$1.66M ﹤0.01% 1291

Other funds holding SWAV

Thrivent Financial for Lutherans's SWAV Position: Q2 2024 in Review

Thrivent Financial for Lutherans sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 117,561 shares — an estimated $38.3M sold.

Thrivent Financial for Lutherans first reported a position in SWAV in Q2 2022 and held it in 8 quarters. The position peaked at $38.3M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Thrivent Financial for Lutherans reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 117,561 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $38.3M.
  • Thrivent Financial for Lutherans first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
  • Thrivent Financial for Lutherans's Shockwave Medical, Inc. Common Stock position peaked at $38.3M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2024, filed 13 Aug 2024.